Itau BBA reiterated an Outperform rating on Banco Bradesco S.A. (BBD) on Feb 27, 2026. This BBD analyst rating was published at 01:15 PM and reflected the firm’s view that Bradesco remains a top pick in Brazilian banks. The note cites the bank’s announced healthcare spin-off as a catalyst. There was no new price target published in the StreetInsider release. Meyka AI rates BBD with a grade of B. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus.

BBD analyst rating: Itau BBA maintains Outperform

Itau BBA formally reiterated Outperform on Feb 27, 2026 at 01:15 PM. The firm said Bradesco remains among its top picks in the Brazilian banking sector. The published note emphasized the bank’s strategic move for a healthcare spin-off as a positive catalyst. The report did not include a fresh price target.

Details of the Feb 27 2026 rating action

StreetInsider published the Itau BBA commentary covering the action and rationale. The exact StreetInsider item is available here. Investing.com also ran a follow-up noting the spin-off and share reaction. Investors should read both pieces for primary context and quotes from the analyst note source.

Price movement, market cap and immediate reaction

At the time of the note the reported intraday price change showed -0.74% (-$0.03) since the previous reference. The published entry lists price as N/A at publication. Banco Bradesco’s market capitalization stands at $43,154,209,074. Short-term trading reflected the spin-off news and the reaffirmed Outperform view rather than a rating upgrade.

What an Outperform rating means for investors

An Outperform rating signals the analyst expects the stock to outperform peers and the sector. For retail investors this implies a higher expected return than a Hold rating. Itau BBA’s reiteration without a new price target suggests conviction in strategy, but not a revised valuation. Investors should pair the rating with balance sheet, ROE, and spin-off specifics before acting.

Historical coverage and analyst context for BBD analyst rating

Itau BBA is a frequent and influential analyst on Brazilian banks and has previously rated Bradesco as a top sector pick. StreetInsider and Investing.com show repeated coverage around strategic corporate moves. Broader analyst coverage has alternated between Neutral and Outperform over the last several years as Brazil macro and credit trends shifted.

Meyka AI view and the stock grade for BBD

Meyka AI rates BBD with a grade of B. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Our AI-powered market analysis flags the healthcare spin-off as a strategic positive, but the lack of a fresh price target keeps upside estimates conservative. These grades are not guarantees and we are not financial advisors.

Final Thoughts

Itau BBA’s reiteration of Outperform on Banco Bradesco S.A. (BBD) on Feb 27, 2026 confirms analyst support for the bank’s strategic direction. The firm cited the announced healthcare spin-off as a key positive but did not publish a new price target. For investors the BBD analyst rating indicates a preference over peers, but it is not a green light to ignore fundamentals. Evaluate balance sheet strength, capital ratios, and projected cash flow from the spin-off. Short-term price moves may be muted; the market showed -0.74% (-$0.03) change in the immediate window. Meyka AI rates BBD with a grade of B, reflecting sector positioning and analyst consensus. Use this B rating as one input among valuation, risk tolerance, and portfolio allocation choices. For ongoing coverage track primary sources from Itau BBA and market wires to capture any follow-up price targets or model updates.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Analyst ratings are opinions and not guarantees of future performance. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.